HIV reservoirs remain obstacles to cure
NIH scientists note need for better understanding of reservoirs' biology
2015-05-19
(Press-News.org) WHAT:
Antiretroviral therapy (ART) has proven lifesaving for people infected with HIV; however, the medications are a lifelong necessity for most HIV-infected individuals and present practical, logistical, economic and health-related challenges. A primary research goal is to find an HIV cure that either clears the virus from an infected person's body or enables HIV-infected individuals to suppress virus levels and replication to extremely low levels without the need for daily ART.
In a new perspective article, National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues describe how persistent HIV reservoirs form in the human body and why they pose formidable challenges to achieving a cure. Additionally, the authors discuss the current therapeutic research strategies aimed at eliminating or controlling the virus without daily ART, including making CD4+ T cells resistant to HIV and enhancing host immunity against infection. A better understanding of persistent viral reservoirs and the impact of therapeutic interventions on these reservoirs is essential to the development of successful therapeutic strategies aimed at the long-term control of HIV infection, according to the authors.
While recent scientific advances and increased funding aimed at developing therapeutic strategies toward an HIV cure have yielded valuable insights into the pathogenesis of HIV-related disease, achieving an HIV cure remains extremely challenging, the authors note. However, recent advances give cause for hope. Attaining a cure will require strong and sustained efforts to better understand the establishment, composition, maintenance, and renewal of HIV reservoirs, according to the authors.
INFORMATION:
ARTICLE:
T-W Chun, S Moir, and AS Fauci. HIV Reservoirs: Obstacles and Opportunities for an HIV Cure. Nature Immunology DOI: 10.1038/ni.3152 (2015).
WHO:
Anthony S. Fauci, M.D, NIAID director, is available for comment.
CONTACT:
To schedule interviews, please contact Robin Tricoles, (301) 402-1663, robin.tricoles@nih.gov.
NIAID conducts and supports research--at NIH, throughout the United States, and worldwide--to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
ELSE PRESS RELEASES FROM THIS DATE:
2015-05-19
Apremilast (trade name: Otezla) has been available since January 2015 for the treatment of moderate to severe plaque psoriasis or active psoriatic arthritis in adult patients in whom certain pretreatments are not sufficiently effective or unsuitable. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in two dossier assessments whether this drug offers an added benefit over the respective appropriate comparator therapy. Such an added benefit cannot be derived from any of the dossiers however, because they contain no relevant data.
Manufacturer ...
2015-05-19
An international team of more than 100 scientists, policy makers and community representatives, led by international conservation charity the Zoological Society of London (ZSL), today published a new report outlining the vital steps needed to save the Hainan gibbon (Nomascus hainanus) from extinction. With only 25 individuals remaining in less than 20 square kilometres of forest in China's Hainan Island, the Critically Endangered Hainan gibbon is one of the rarest animals in the world.
The last surviving Hainan gibbon population contains only three social groups, in ...
2015-05-19
Suffering from anxiety or depression could carry an increased risk of death from liver disease, a study suggests.
The study is the first to identify a possible link between high levels of psychological distress and deaths resulting from a variety of liver diseases.
Reasons for this are unclear as the biological links between psychological distress and liver disease are not well understood, researchers say.
Previous research suggests mental distress can put people at increased risk of cardiovascular disease. At the same time, risk factors for cardiovascular disease ...
2015-05-19
(PARIS, FRANCE) -- Experts speaking at EuroPCR 2015 say the explosion of positive results for new-generation endovascular devices for the treatment of acute stroke warrant a call to action to ensure swifter implementation of this technology. Known as "stent-retrievers," mechanical thrombectomy devices use catheters introduced into a blocked cerebral artery to suck out or lyse a clot that is cutting off circulation to part of the brain.
On Tuesday, EuroPCR 2015 featured a special breaking news session devoted to this rapidly evolving field to review the recent evidence ...
2015-05-19
(PARIS, FRANCE) - Experts participating in a European Clinical Consensus Conference (CCC) have concluded that research into the use of renal denervation for high blood pressure in patients unable to control the disease using a multi-drug regimen should not be abandoned until high-quality research is completed according to agreed-upon standards. [1]
"Focused, collaborative high-quality research will be necessary to ensure that future patients are neither denied an effective therapy, nor needlessly put at risk from procedures that bring no benefits," the authors, led by ...
2015-05-19
Sending teen girls periodic text messages reminding them to follow through on their clinic appointments for periodic birth control injections can go a long way toward improving timing and adherence to contraception in an age group that is notoriously noncompliant, according to a small study from the Johns Hopkins Children's Center.
"Our findings suggest that text messaging can help overcome some issues that teens struggle with and pose challenges for the clinicians caring for them, such as keeping clinical appointments, adhering to a tight treatment schedule and regularly ...
2015-05-19
There is a striking and statistically significant difference in how women and men are treated following a heart attack. These gender differences are reflected in the rate of risk factor control, which was lower in women, and in the rate of hospital readmission for a further heart attack, which was higher in women than in men.
The conclusions are reported today in an analysis of the SWEDEHEART registry in the European Journal of Preventive Cardiology.(1) This Swedish registry is one of the world's biggest ongoing statistical records in cardiac treatments and one of the ...
2015-05-18
Thirty-five million people worldwide are currently living with HIV-1/AIDS. Broadly neutralizing antibodies (bnAbs) have been isolated from some patients with HIV-1, and these antibodies recognize and inhibit a range of HIV-1 variants. Strategies to enhance the potency and breadth of these bnAbs have the potential to inform the development of an effective HIV-1 vaccine. A new study in the Journal of Clinical Investigation reveals that increasing the stability of an HIV-1-targeting bnAb improves efficacy. James Crowe and colleagues at Vanderbilt University used computational ...
2015-05-18
COLUMBUS, Ohio - Chest pain is a scary symptom that sends more than 7 million Americans to the emergency department each year. About half of them are admitted to the hospital for further observation, testing or treatment. Now, emergency medicine physicians at The Ohio State University Wexner Medical Center and Mount Carmel Health System believe that number can be significantly reduced.
Their study, published in today's JAMA Internal Medicine, finds a very low short-term risk for life-threatening cardiac events among patients with chest pain who have normal cardiac blood ...
2015-05-18
SAN FRANCISCO, May 18, 2015 -- Prescribing patients two or more drugs that do not reach the same parts of the body could accelerate a pathogen's resistance to all of the drugs being used in treatment, according to a new study published today in the Proceedings of the National Academy of Sciences.
Not all drugs can reach all parts of the body, a situation known as "imperfect drug penetration." In the study, researchers found that when there is a "pocket" of the body where only one drug is present, such as the brain or the digestive system, a pathogen can quickly develop ...
LAST 30 PRESS RELEASES:
[Press-News.org] HIV reservoirs remain obstacles to cure
NIH scientists note need for better understanding of reservoirs' biology
